@article{ATM24510,
author = {Kyle G. Mitchell and Mara B. Antonoff},
title = {Encouraging early outcomes in cancer and leukemia group B (CALGB)/Alliance 140503: patient selection, not extent of resection, is the key to perioperative success},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 1},
year = {2019},
keywords = {},
abstract = {After the Lung Cancer Study Group published its seminal trial in 1995, anatomic lobectomy was established as the gold standard surgical therapy for patients with resectable non-small cell lung cancer (NSCLC) (1). However, the increasing utilization of low-dose helical computed tomography (CT) as a screening strategy in high-risk patients and the resultant increase in the frequency of diagnosis of smaller, more peripheral lesions has reinvigorated interest in the oncologic merits of sublobar resection (2). A host of retrospective studies have suggested that sublobar resection provides equivalent locoregional disease control while sparing lung parenchyma (3-5). Consequently, sublobar resection is frequently offered to patients with marginal pulmonary function or to those whose comorbidities render them to be otherwise borderline surgical candidates.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/24510}
}